Dipeptidyl peptidase-4 and kidney fibrosis in diabetes

Diabetic nephropathy (DN) is the most common cause of end-stage kidney disease worldwide and is associated with increased morbidity and mortality in patients with both type 1 and type 2 diabetes. Recent evidence revealed that dipeptidyl peptidase-4 (DPP-4) inhibitors may exhibit a protective effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Sen, Koya, Daisuke, Kanasaki, Keizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752740/
https://www.ncbi.nlm.nih.gov/pubmed/26877767
http://dx.doi.org/10.1186/s13069-016-0038-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752740/
https://www.ncbi.nlm.nih.gov/pubmed/26877767
http://dx.doi.org/10.1186/s13069-016-0038-0

Ejemplares similares